What's new

Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 7, Status: Authorised

Mar 28, 2025 - 16:56
 0
Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

Visby Medical nets FDA clearance for completely at-home STI test

Next Article

NAR’s Clear Cooperation Policy tweak: Inman’s Top 5

Related Posts

Human medicines European public assessment report (EPAR): Efient, prasugrel, Date of authorisation: 24/02/2009, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0

Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Date of authorisation: 12/12/2024, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 6, 2025  0

Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR...

Mar 28, 2025  0